Haplotype analysis of UDP-glucuronocyltransferase 2B7 gene (UGT2B7) polymorphisms in healthy Japanese subjects. 2006

Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
Division of Pharmaceutical Health Care and Sciences, Sapporo Medical University, Chuo-ku, Sapporo 060-8543, Japan. ksaito@sapmed.ac.jp

OBJECTIVE UDP-glucuronocyltransferase 2B7 (UGT2B7) catalyzes glucuronidation of various types of endogenous compounds and drugs, but the genetic basis of interindividual variation in the metabolism of these substances has not yet been sufficiently elucidated. In addition, information about single nucleotide polymorphisms (SNPs) and haplotypes of the UGT2B7 gene that encode the enzyme in the Japanese population is still far from sufficient. METHODS We paid special attention to and performed an investigation on -327A > G, -161T > C, -138G > A, and -125T > C in the proximal promoter region, which is regarded as being important for the transcription of the UGT2B7 gene, and also on 211G > A and 802C > T, i.e., non-synonymous SNPs of exon 1 and exon 2 that encode the substrate binding domain. Their genotypes were determined by PCR-direct sequencing. RESULTS As a result of genotyping, the minor allele frequencies in 160 Japanese individuals were found to be as follows: -327SNP A allele, 0.244; -161SNP T allele, 0.244; -138SNP A allele, 0; -125SNP C allele, 0.078; 211SNP T allele, 0.148 and 802SNP T allele, 0.244. By computational haplotype analysis, it was found that these regions formed a linkage disequilibrium block, and the presence of five haplotypes was demonstrated. CONCLUSIONS These results suggest that the haplotype structure in the Japanese population is different from that of other ethnic groups.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D005091 Exons The parts of a transcript of a split GENE remaining after the INTRONS are removed. They are spliced together to become a MESSENGER RNA or other functional RNA. Mini-Exon,Exon,Mini Exon,Mini-Exons
D005787 Gene Frequency The proportion of one particular in the total of all ALLELES for one genetic locus in a breeding POPULATION. Allele Frequency,Genetic Equilibrium,Equilibrium, Genetic,Allele Frequencies,Frequencies, Allele,Frequencies, Gene,Frequency, Allele,Frequency, Gene,Gene Frequencies
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014453 Glucuronosyltransferase A family of enzymes accepting a wide range of substrates, including phenols, alcohols, amines, and fatty acids. They function as drug-metabolizing enzymes that catalyze the conjugation of UDPglucuronic acid to a variety of endogenous and exogenous compounds. EC 2.4.1.17. Glucuronyltransferase,UDP Glucuronosyltransferase,17 beta-Hydroxysteroid UDP-Glucuronosyltransferase,4-Nitrophenol-UDP-Glucuronosyltransferase,7-Hydroxycoumarin UDP Glucuronyltransferase,Androsterone UDP-Glucuronosyltransferase,Bilirubin UDP-Glucuronyltransferase,Estrogen UDP-Glucuronosyltransferase,Estrone Glucuronyltransferase,Glucuronic Transferase,Morphine Glucuronyltransferase,UDP Glucuronyl Transferase,UDP-Glucuronic Acid 3-O-beta-D-Galactosyl-D-Galactose Glucuronosyltransferase,p-Nitrophenyl UDP-Glucuronosyltransferase,17 beta Hydroxysteroid UDP Glucuronosyltransferase,4 Nitrophenol UDP Glucuronosyltransferase,7 Hydroxycoumarin UDP Glucuronyltransferase,Androsterone UDP Glucuronosyltransferase,Bilirubin UDP Glucuronyltransferase,Estrogen UDP Glucuronosyltransferase,Glucuronosyltransferase, UDP,Glucuronyl Transferase, UDP,Glucuronyltransferase, 7-Hydroxycoumarin UDP,Glucuronyltransferase, Estrone,Glucuronyltransferase, Morphine,Transferase, Glucuronic,Transferase, UDP Glucuronyl,UDP Glucuronic Acid 3 O beta D Galactosyl D Galactose Glucuronosyltransferase,UDP Glucuronyltransferase, 7-Hydroxycoumarin,UDP-Glucuronosyltransferase, 17 beta-Hydroxysteroid,UDP-Glucuronosyltransferase, Androsterone,UDP-Glucuronosyltransferase, Estrogen,UDP-Glucuronosyltransferase, p-Nitrophenyl,UDP-Glucuronyltransferase, Bilirubin,p Nitrophenyl UDP Glucuronosyltransferase
D015810 Linkage Disequilibrium Nonrandom association of linked genes. This is the tendency of the alleles of two separate but already linked loci to be found together more frequently than would be expected by chance alone. Disequilibrium, Linkage,Disequilibriums, Linkage,Linkage Disequilibriums
D044466 Asian People Persons having origins in any of the Asian racial groups of the Far East, Southeast Asia, or the Indian subcontinent including, for example, Cambodia, China, India, Japan, Korea, Malaysia, Pakistan, the Philippine Islands, Thailand, and Vietnam. Note that OMB category ASIAN is available for United States population groups. Race and ethnicity terms, as used in the federal government, are self-identified social construct and may include terms outdated and offensive in MeSH to assist users who are interested in retrieving comprehensive search results for studies such as in longitudinal studies. Asian Continental Ancestry Group,Asian Person,Asiatic Race,Mongoloid Race,Asian Peoples,Asian Persons,Asiatic Races,Mongoloid Races,People, Asian,Person, Asian,Race, Asiatic,Race, Mongoloid
D020641 Polymorphism, Single Nucleotide A single nucleotide variation in a genetic sequence that occurs at appreciable frequency in the population. SNPs,Single Nucleotide Polymorphism,Nucleotide Polymorphism, Single,Nucleotide Polymorphisms, Single,Polymorphisms, Single Nucleotide,Single Nucleotide Polymorphisms

Related Publications

Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
January 2010, Drug metabolism and pharmacokinetics,
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
May 2014, Drug metabolism and disposition: the biological fate of chemicals,
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
January 2003, The pharmacogenomics journal,
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
September 2004, Drug metabolism and disposition: the biological fate of chemicals,
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
May 2000, Drug metabolism and disposition: the biological fate of chemicals,
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
December 2011, Biochemical pharmacology,
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
September 2020, Hormones (Athens, Greece),
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
October 2021, Biomolecular NMR assignments,
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
November 2000, Pharmacogenetics,
Katsuhiko Saito, and Hiroyuki Moriya, and Takeru Sawaguchi, and Takako Hayakawa, and Seiya Nakahara, and Akira Goto, and Yoshiaki Arimura, and Kohzoh Imai, and Nahoko Kurosawa, and Eiji Owada, and Atsushi Miyamoto
January 2011, European journal of clinical pharmacology,
Copied contents to your clipboard!